BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15693807)

  • 1. Use of the headache impact test (HIT-6) in general practice: relationship with quality of life and severity.
    Nachit-Ouinekh F; Dartigues JF; Henry P; Becg JP; Chastan G; Lemaire N; El Hasnaoui A
    Eur J Neurol; 2005 Mar; 12(3):189-93. PubMed ID: 15693807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of headache on quality of life in a general population survey in France (GRIM2000 Study).
    Duru G; Auray JP; Gaudin AF; Dartigues JF; Henry P; Lantéri-Minet M; Lucas C; Pradalier A; Chazot G; El Hasnaoui A
    Headache; 2004 Jun; 44(6):571-80. PubMed ID: 15186301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients.
    Smelt AF; Assendelft WJ; Terwee CB; Ferrari MD; Blom JW
    Cephalalgia; 2014 Jan; 34(1):29-36. PubMed ID: 23843470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
    Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
    Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Migraine in general practice. A French multicenter study].
    Fabre N; Nachit-Ouinekh F; Becq JP; Chastan G; Sénard JM; El Hasnaoui A
    Rev Neurol (Paris); 2005 Oct; 161(10):949-56. PubMed ID: 16365624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIDAS and HIT-6 French translation: reliability and correlation between tests.
    Magnoux E; Freeman MA; Zlotnik G
    Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain beliefs and perceptions inventory: a cross-sectional study in chronic and episodic migraine.
    Condello C; Piano V; Dadam D; Pinessi L; Lantéri-Minet M
    Headache; 2015 Jan; 55(1):136-48. PubMed ID: 25545038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT).
    Bayliss MS; Dewey JE; Dunlap I; Batenhorst AS; Cady R; Diamond ML; Sheftell F
    Qual Life Res; 2003 Dec; 12(8):953-61. PubMed ID: 14651414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of migraine severity using the MIGSEV scale: relationship to migraine features and quality of life.
    El Hasnaoui A; Vray M; Blin P; Nachit-Ouinekh F; Boureau F;
    Cephalalgia; 2004 Apr; 24(4):262-70. PubMed ID: 15030534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales.
    Bjorner JB; Kosinski M; Ware JE
    Qual Life Res; 2003 Dec; 12(8):981-1002. PubMed ID: 14651417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of headache severity on quality of life of patients with migraine.
    Simić S; Slankamenac P; Cvijanović M; Ilin M; Kopitović A
    Med Pregl; 2006; 59(7-8):299-304. PubMed ID: 17140027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache-related disability among medical students in Amazon: a cross-sectional study.
    Almeida CM; Lima PA; Stabenow R; Mota RS; Boechat AL; Takatani M
    Arq Neuropsiquiatr; 2015 Dec; 73(12):1009-13. PubMed ID: 26677121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A six-item short-form survey for measuring headache impact: the HIT-6.
    Kosinski M; Bayliss MS; Bjorner JB; Ware JE; Garber WH; Batenhorst A; Cady R; Dahlöf CG; Dowson A; Tepper S
    Qual Life Res; 2003 Dec; 12(8):963-74. PubMed ID: 14651415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tools for assessing patient perception of the impact of migraine].
    El Hasnaoui A; Doble A; Gaudin AF
    CNS Drugs; 2006; 20 Spec no.1():24-36. PubMed ID: 16841524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
    Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
    Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.